pubmed-article:15453640 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15453640 | lifeskim:mentions | umls-concept:C0007600 | lld:lifeskim |
pubmed-article:15453640 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:15453640 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
pubmed-article:15453640 | lifeskim:mentions | umls-concept:C1518174 | lld:lifeskim |
pubmed-article:15453640 | lifeskim:mentions | umls-concept:C0012854 | lld:lifeskim |
pubmed-article:15453640 | lifeskim:mentions | umls-concept:C0042874 | lld:lifeskim |
pubmed-article:15453640 | lifeskim:mentions | umls-concept:C0311404 | lld:lifeskim |
pubmed-article:15453640 | lifeskim:mentions | umls-concept:C1883709 | lld:lifeskim |
pubmed-article:15453640 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:15453640 | pubmed:dateCreated | 2004-9-29 | lld:pubmed |
pubmed-article:15453640 | pubmed:abstractText | Expression of multiple drug resistant (MDR) phenotype and over-expression of P-glycoprotein (P-gp) in the human hepatocellular carcinoma (HCC) cell clone P1(0.5), derived from the PLC/PRF/5 cell line (P5), are associated with strong resistance to oxidative stress and a significant (p < 0.01) increase in intracellular vitamin E content as compared with the parental cell line. This study evaluates the role of vitamin E in conferring resistance to drugs and oxidative stress in P1(0.5) cells. Parental drug-sensitive cells, P5, were incubated in alpha-tocopherol succinate (alpha-TS, 5 microM for 24 h) enriched medium to increase intracellular vitamin E content to levels comparable to those observed in P1(0.5) cells at basal conditions. Susceptibility to lipid peroxidation and oxidative DNA damage were assessed by measuring the concentration of thiobarbituric-reactive substances (TBARS) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) at basal and after experimental conditions. Cell capacity to form colonies and resistance to doxorubicin were also studied. P5 cells, treated with alpha-TS, became resistant to ADP-Fe3+ and to ionizing radiation-induced lipid peroxidation as P1(0.5) cells. Exposure to ADP-Fe3+ or ionizing radiation increased TBARS and the 8-OHdG content in the P5 cells, while vitamin E enrichment abolished these effects. Irradiation doses at 5 cGy increased TBARS and 8-OHdG. They also inhibited cell capacity to form colonies in the untreated P5 cells. Incubation with alpha-TS fully reverted this effect and significantly (p < 0.01) reduced the inhibitory effect of cell proliferation induced by irradiation doses at >500 cGy. Resistance to doxorubicin was not affected by alpha-TS. These observations demonstrate the role of vitamin E in conferring protection from lipid peroxidation, ionizing radiation and oxidative DNA damage on the human HCC cell line. They also rule out any role of P-gp over-expression as being responsible for these observations in cells with MDR phenotype expression. | lld:pubmed |
pubmed-article:15453640 | pubmed:language | eng | lld:pubmed |
pubmed-article:15453640 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15453640 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15453640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15453640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15453640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15453640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15453640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15453640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15453640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15453640 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15453640 | pubmed:month | Jul | lld:pubmed |
pubmed-article:15453640 | pubmed:issn | 1071-5762 | lld:pubmed |
pubmed-article:15453640 | pubmed:author | pubmed-author:FantappièOrne... | lld:pubmed |
pubmed-article:15453640 | pubmed:author | pubmed-author:SolazzoMichel... | lld:pubmed |
pubmed-article:15453640 | pubmed:author | pubmed-author:MazzantiRober... | lld:pubmed |
pubmed-article:15453640 | pubmed:author | pubmed-author:FabrizioPaola... | lld:pubmed |
pubmed-article:15453640 | pubmed:author | pubmed-author:PantaleoPietr... | lld:pubmed |
pubmed-article:15453640 | pubmed:author | pubmed-author:FabbroniValen... | lld:pubmed |
pubmed-article:15453640 | pubmed:author | pubmed-author:LodoviciMaura... | lld:pubmed |
pubmed-article:15453640 | pubmed:author | pubmed-author:LasagnaNadiaN | lld:pubmed |
pubmed-article:15453640 | pubmed:author | pubmed-author:MarchettiaSer... | lld:pubmed |
pubmed-article:15453640 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15453640 | pubmed:volume | 38 | lld:pubmed |
pubmed-article:15453640 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15453640 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15453640 | pubmed:pagination | 751-9 | lld:pubmed |
pubmed-article:15453640 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:15453640 | pubmed:meshHeading | pubmed-meshheading:15453640... | lld:pubmed |
pubmed-article:15453640 | pubmed:meshHeading | pubmed-meshheading:15453640... | lld:pubmed |
pubmed-article:15453640 | pubmed:meshHeading | pubmed-meshheading:15453640... | lld:pubmed |
pubmed-article:15453640 | pubmed:meshHeading | pubmed-meshheading:15453640... | lld:pubmed |
pubmed-article:15453640 | pubmed:meshHeading | pubmed-meshheading:15453640... | lld:pubmed |
pubmed-article:15453640 | pubmed:meshHeading | pubmed-meshheading:15453640... | lld:pubmed |
pubmed-article:15453640 | pubmed:meshHeading | pubmed-meshheading:15453640... | lld:pubmed |
pubmed-article:15453640 | pubmed:meshHeading | pubmed-meshheading:15453640... | lld:pubmed |
pubmed-article:15453640 | pubmed:meshHeading | pubmed-meshheading:15453640... | lld:pubmed |
pubmed-article:15453640 | pubmed:meshHeading | pubmed-meshheading:15453640... | lld:pubmed |
pubmed-article:15453640 | pubmed:meshHeading | pubmed-meshheading:15453640... | lld:pubmed |
pubmed-article:15453640 | pubmed:meshHeading | pubmed-meshheading:15453640... | lld:pubmed |
pubmed-article:15453640 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15453640 | pubmed:articleTitle | Vitamin E protects DNA from oxidative damage in human hepatocellular carcinoma cell lines. | lld:pubmed |
pubmed-article:15453640 | pubmed:affiliation | Department of Internal Medicine, U.A. Oncologia, Azienda Ospedaliero-Universitaria Careggi, Viale G.B. Morgagni 85, I-50134 Florence, Italy. | lld:pubmed |
pubmed-article:15453640 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15453640 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |